Meet our colleagues!
First out is Zoltán Németh, Senior Research Analyst in the Modelling, Access and Strategy unit. Zoltán joined Quantify Research Stockholm at the end of last summer and quickly became an integral part of the […]
First out is Zoltán Németh, Senior Research Analyst in the Modelling, Access and Strategy unit. Zoltán joined Quantify Research Stockholm at the end of last summer and quickly became an integral part of the […]
The Quantify Research team has years of experience of designing, supporting, and managing post-authorization studies, and has been a proud partner to the European Medicines Agency-coordinated ENCePP (European Network for Centres of Pharmacoepidemiology and Pharmacovigilance) […]
This week the Quantify Research team started early by going to Golfbaren Sverige for a round of mini golf on Thursday night. ⛳
The sun was shining and the competitive spirits ran high!
A big shout […]
In April 2024, Quantify’s Helena Skröder and Nicholas Norton published a study quantifying the burden of acute otitis media (AOM) caused by pneumoniae, after widespread use of PCVs. The review found […]
The Quantify team enjoyed reconnecting with colleagues, meeting new faces, presenting our research, and drawing inspiration from the scientific program.
We’re already excited for ISPOR EU in Barcelona! If we didn’t get a chance to meet or if you’d like to […]

As Day 2 at ISPOR annual comes to close, the Quantify team is feeling thankful for another day connecting with industry colleagues, partners, and some great programming. If we haven’t see you […]
The Quantify team had a great first day at ISPOR and we’re looking forward to what tomorrow has in store. Drop by booth 337 to say hello!
Also – don’t miss our poster on the Economic Burden of Prescription Opioid Abuse in […]
Quantify Research is recognized as one of the 10 most cited publications last year in the renowned journal Alzheimer’s & Dementia!
Our work with Project Alzheimer Value Europe titled “Global estimates on the number of […]
“This cohort patient study provides an invaluable blueprint to inform future treatment decision-making and support optimal use of romosozumab in clinical practice, both in Denmark and across Europe,” said Emmanuel Caeymaex, Executive Vice President, Immunology and U.S. Solutions at […]